Frequent Vaping Linked to Lung Function Decline in Young Adults, Preliminary Study Finds

A first indicator, not a settled conclusion
The authors call their small vaping and lung function study a first signal that needs longer, controlled follow-up.
Mark

Start with the basics. What did the researchers actually do?

Mimi

They tested the lungs of 22 young adults who mostly vaped, once at the start and again about a year later, and compared the results.

Mark

And what changed?

Mimi

FEV1, the amount of air you can exhale in one second, fell significantly between the two tests. That measure is closely tied to COPD.

Luke

Before we go further, the dose-response part needs care. The decline did grow with vaping frequency, but that trend was not statistically significant.

Mimi

Right. The numbers were 100 ml for 5 to 9 times a day, 190 ml for 10 to 29, and 240 ml for 30 or more, all compared with people vaping 0 to 4 times.

Mark

So the pattern is suggestive but not proven?

Luke

That's fair. And with 22 people, a few individuals could move those averages a lot.

Mimi

The authors admit that, along with having just two time points.

Luke

The bigger gap is the missing comparison group. Without tobacco-free controls, we can't say how a year of vaping compares with a year without it.

Mark

Yet the authors call the evidence credible. Is that stronger than the data allows?

Luke

That's their characterization. They also say an accelerated decline needs longer observation, so they're hedging too. Whether this leads to COPD is still unknown.

Mimi

What stands is a first signal, and the next step is a bigger, longer study.

  • Twenty-two young e-cigarette users returned a year later to find their lungs measurably weaker on the key breath test.
  • The drop in one-second airflow mirrors a warning sign doctors associate with COPD, raising alarm about long-term damage.
  • Daily vaping frequency tracked with bigger losses, reaching roughly 240 ml for those puffing thirty or more times a day, though the trend fell short of statistical significance.
  • Researchers are navigating a small sample, only two measurements, and no tobacco-free comparison group, so they are calling for larger, longer studies before drawing firm conclusions.
  • The finding is landing as a serious signal worth pursuing rather than a settled answer, leaving public health questions open for now.

In a small, preliminary study published in Tobacco Control, a group of twenty-two young adults who mostly vaped was followed for about a year, and their lung capacity was measured at the start and again at the end. Over that span, the air they could forcefully expel in one second dropped measurably, and the heavier the daily vaping, the steeper the apparent slide, though the pattern did not clear the threshold of statistical certainty. The researchers, careful about their own limits, present this less as a verdict than as an early warning: a hint that the slow, cumulative toll of a habit now common among the young may be quieter, and perhaps more consequential, than its novelty suggests.

Twenty-two young adults, most of them primarily e-cigarette users aged 21 to 35, took a set of lung function tests at the start of a small study. About twelve months later, they returned and sat for the same tests again. The results, published in Tobacco Control, are preliminary, and the researchers say so openly. Still, they point somewhere that deserves attention.

Each session was held in the morning, twelve hours after the last use of any tobacco product, and participants reported how often they vaped each day. The tests tracked how much air a person could blow out in the first second, the total volume they could exhale after a deep breath, and the ratio between the two. By the second round, the first-second figure had dropped significantly. That matters because this kind of decline is a hallmark of chronic obstructive pulmonary disease, a serious and life-limiting condition, and the team suggests that long-term vaping may raise the risk of developing it.

After adjusting for age, sex, race, height and vaping frequency, the researchers saw a downward trend as daily use increased, though it did not reach statistical significance. Compared with those vaping up to four times a day, people using five to nine times lost about 100 ml, those using ten to twenty-nine times lost about 190 ml, and those using thirty or more times lost about 240 ml.

The authors are frank about the limits: a small group, only two time points, and no non-tobacco comparison group, which makes it hard to know how much of the decline belongs to vaping alone. They nonetheless describe the work as a first indicator that prolonged use could have lasting, clinically meaningful effects. What comes next is larger, longer research with more participants, repeated measurements and tobacco-free controls. Until then, the finding is a signal to follow rather than a settled conclusion.

Twenty-two young adults, all of them primarily e-cigarette users between the ages of 21 and 35, sat for a set of lung function tests at the start of a small study. They came back an average of 12 months later and sat for the same tests again. The results, published online in the journal Tobacco Control, are preliminary, and the researchers say so plainly. But they point in a direction that merits attention.

The tests were run between 9:00 and 11:00 in the morning, 12 hours after participants last used any tobacco product. Participants also reported how often they vaped each day. The tests measured three things: forced expiratory volume in the first second, or FEV1, which is how much air a person can blow out in one second; forced vital capacity, the total volume that can be forcefully and rapidly exhaled after a deep breath; and the ratio between the two.

At the second round of testing, FEV1 had dropped significantly. That matters because a decline in FEV1 is a hallmark of chronic obstructive pulmonary disease, or COPD, a life-limiting condition. The researchers suggest that the cumulative effects of long-term vaping might raise the risk of developing it.

The team then adjusted for vaping frequency and for factors that could influence lung function, including age, sex, race and height. After that adjustment, FEV1 showed a declining trend as daily vaping increased, although that trend did not reach statistical significance.

The figures were measured against participants who vaped 0 to 4 times a day. Those who vaped 5 to 9 times a day saw a fall of 100 ml in FEV1. Those who vaped 10 to 29 times a day saw a fall of 190 ml. And those who vaped 30 or more times a day saw a decline of 240 ml.

The authors are open about the study's limits. The sample is small. It relied on only two time points to assess the chronic effects of e-cigarettes on pulmonary function. And it had no tobacco-free comparison group, which makes it harder to say how much of the decline is specific to vaping.

Even so, they argue that the work "provides credible evidence of the effect of prolonged exposure to e-cigarette use on the pulmonary functions of young adults and its dose-response relation." They add that an accelerated decline in FEV1 will require longer observation and tobacco-free controls to confirm, but that the study offers a first indicator that prolonged e-cigarette use could have persistent, clinically important cumulative effects on FEV1 and pose a COPD risk.

What comes next is larger, longer research, with more participants, repeated measurements over time and a comparison group that does not use tobacco. Until then, the finding stands as a signal worth following rather than a settled conclusion.

provides credible evidence of the effect of prolonged exposure to e-cigarette use on the pulmonary functions of young adults and its dose-response relation.
— Study researchers, Tobacco Control
Envie de l'histoire complète ? Lire l'original sur News-Medical ↗
Nous contacter FAQ